The effect of haemodialysis on the pharmacokinetics of tenoxicam in patients with end-stage renal disease

European Journal of Clinical Pharmacology
M S al-GhamdiI S al-Saeed

Abstract

We have studied the pharmacokinetics of tenoxicam after single and multiple oral doses of 20 mg in five patients (2 men and 3 women) with end-stage renal disease undergoing haemodialysis. After a single dose, tenoxicam had a half-life (t1/2) of 33 h, an apparent clearance (CL.f-1) of 4.3 ml.min-1, and an apparent volume of distribution (Vz.f-1) of 11.81. The maximum tenoxicam concentration (Cmax) was 4.3 mg.l-1 at a median tmax of 1.7 h. There were no significant differences between the values calculated from the pre- or post-dialyser port plasma samples. Tenoxicam plasma concentrations measured during once daily dosing before and after haemodialysis showed that tenoxicam does not accumulate. Our findings suggest that dosage adjustment may not be required in patients with end-stage renal disease on haemodialysis taking tenoxicam.

References

Jan 10, 1986·Journal of Chromatography·P HeizmannK Zinapold
Jan 1, 1986·European Journal of Clinical Pharmacology·F F HorberF J Frey
Nov 1, 1985·British Journal of Rheumatology·H A BirdV Wright
Sep 1, 1984·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S IchiharaR Joly

❮ Previous
Next ❯

Citations

Feb 13, 2014·Seminars in Dialysis·Sara N DavisonFrank Brennan
Jan 13, 2015·Clinical Pharmacokinetics·Charles E FrostFrank LaCreta
Mar 7, 2009·Journal of Industrial Microbiology & Biotechnology·S Kebbouche-GanaH Hacene
Jul 8, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Rebecca PellicanoPeter G Kerr
Nov 15, 2002·Oncology Nursing Forum·Cynthia R KingCatherine Lee
Sep 18, 2012·Journal of Lesbian Studies·Sahar Amer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Clinical Pharmacology
F F HorberF J Frey
European Journal of Drug Metabolism and Pharmacokinetics
C CrevoisierU C Dubach
© 2021 Meta ULC. All rights reserved